<qa>  What is the Phase 2 Dose?Dose Escalation Part 1: To evaluate safety, pharmacokinetics, pharmacodynamics of PLX8394 in adults and pediatrics with advanced BRAF- mutated tumors, and to identify the recommended Phase 2 Dose. 